Xpamac
Szeged, HU · 1 known investors
XPAMAC Inc. develops next-generation mammalian cell lines using a proprietary "Mammalian Elongated Chromosome" (MEC) platform for the stable, scalable production of therapeutic proteins, including monoclonal antibodies and other difficult-to-express biologics. It provides cell line development services to CDMOs, research centers, and pharma and biotech companies.
Founders & leadership
VT
Vilmos TubakCEO of Creative Laboratory Ltd. / MEC technology lead
AS
Attila SzvetnikProtein expression and engineering specialist
Board
TM
Tamás MartinekProfessor / Scientific collaborator
Investors · 1
Frequently asked questions
- What does Xpamac do?
- XPAMAC Inc. develops next-generation mammalian cell lines using a proprietary "Mammalian Elongated Chromosome" (MEC) platform for the stable, scalable production of therapeutic proteins, including monoclonal antibodies and other difficult-to-express biologics. It provides cell line development services to CDMOs, research centers, and pharma and biotech companies.
- Who are Xpamac's investors?
- Xpamac's investors include Vespucci Partners.
- Where is Xpamac headquartered?
- Xpamac is headquartered in Szeged, HU.